Trial Review

Technical difficulties have been reported by some users of the search function and is being investigated by technical staff. Thank you for your patience and apologies for any inconvenience caused.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT06025578




Registration number
NCT06025578
Ethics application status
Date submitted
30/08/2023
Date registered
6/09/2023
Date last updated
14/06/2024

Titles & IDs
Public title
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
Scientific title
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
Secondary ID [1] 0 0
2023-503699-25
Secondary ID [2] 0 0
IM027-1015
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Progressive Pulmonary Fibrosis 0 0
Condition category
Condition code
Respiratory 0 0 0 0
Other respiratory disorders / diseases
Inflammatory and Immune System 0 0 0 0
Connective tissue diseases
Inflammatory and Immune System 0 0 0 0
Other inflammatory or immune system disorders

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Drugs - BMS-986278
Treatment: Drugs - BMS-986278 Placebo

Experimental: BMS-986278 Dose 1 -

Experimental: BMS-986278 Dose 2 -

Placebo comparator: BMS-986278 Placebo -


Treatment: Drugs: BMS-986278
Specified dose on specified days

Treatment: Drugs: BMS-986278 Placebo
Specified dose on specified days
Intervention code [1] 0 0
Treatment: Drugs
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Number of participants that experience spontaneous syncopal events
Timepoint [1] 0 0
At approximately 4 weeks
Primary outcome [2] 0 0
Absolute change from baseline in forced vital capacity (FVC) measured in mL
Timepoint [2] 0 0
At Week 52
Secondary outcome [1] 0 0
Number of participants who discontinued treatment due to any low BP-related Adverse Events
Timepoint [1] 0 0
Up to approximately 3 years
Secondary outcome [2] 0 0
Disease progression
Timepoint [2] 0 0
Up to approximately 3 years
Secondary outcome [3] 0 0
Change from baseline in Living with Pulmonary Fibrosis Questionnaire (L-PF) cough domain score
Timepoint [3] 0 0
At Week 52 and up to approximately 3 years
Secondary outcome [4] 0 0
Change from baseline in L-PF dyspnea domain score
Timepoint [4] 0 0
At Week 52 and up to approximately 3 years
Secondary outcome [5] 0 0
Change from baseline in walking distance measured in 6-minute walk test (6MWT)
Timepoint [5] 0 0
At Week 52
Secondary outcome [6] 0 0
Time to the first occurrence of any of the components of the composite endpoint: time to first acute exacerbation of pulmonary fibrosis, first respiratory-related hospitalization, or all-cause mortality
Timepoint [6] 0 0
Up to approximately 3 years
Secondary outcome [7] 0 0
Time to absolute percent ppFVC decline of = 10% from baseline
Timepoint [7] 0 0
Up to approximately 3 years
Secondary outcome [8] 0 0
Time to first acute exacerbation of pulmonary fibrosis
Timepoint [8] 0 0
Up to approximately 3 years
Secondary outcome [9] 0 0
Time to first respiratory-related hospitalization
Timepoint [9] 0 0
Up to approximately 3 years
Secondary outcome [10] 0 0
Time to first pulmonary fibrosis-related hospitalization.
Timepoint [10] 0 0
Up to approximately 3 years
Secondary outcome [11] 0 0
Time to all-cause mortality
Timepoint [11] 0 0
Up to approximately 3 years
Secondary outcome [12] 0 0
Change from baseline in L-PF fatigue domain score
Timepoint [12] 0 0
At Week 52 and up to approximately 3 years
Secondary outcome [13] 0 0
Change from baseline in L-PF impacts module score
Timepoint [13] 0 0
At Week 52 and up to approximately 3 years
Secondary outcome [14] 0 0
Change from baseline in cough numeric rating scale (NRS)
Timepoint [14] 0 0
At Week 52 and up to approximately 3 years
Secondary outcome [15] 0 0
Change from baseline in EuroQol 5 Dimension 5 Level (EQ-5D-5L) health utility index score
Timepoint [15] 0 0
At Week 52
Secondary outcome [16] 0 0
Change from baseline in EQ-5D-5L visual analog scale score
Timepoint [16] 0 0
At Week 52
Secondary outcome [17] 0 0
Rate of decline from baseline in FVC (mL)
Timepoint [17] 0 0
At Week 52
Secondary outcome [18] 0 0
Rate of decline in ppFVC from baseline
Timepoint [18] 0 0
At Week 52
Secondary outcome [19] 0 0
Change in ppFVC from baseline
Timepoint [19] 0 0
At Week 52
Secondary outcome [20] 0 0
Proportion of participants with absolute decline in ppFVC =10%
Timepoint [20] 0 0
At Week 52
Secondary outcome [21] 0 0
Proportion of participants with relative decline in ppFVC =10%
Timepoint [21] 0 0
At Week 52
Secondary outcome [22] 0 0
Change from baseline in single-breath diffusing capacity of the lung for carbon monoxide (DLCO SB) (corrected for hemoglobin) (mL/min/mm Hg)
Timepoint [22] 0 0
At Week 52
Secondary outcome [23] 0 0
Change in percent predicted single breath diffusing capacity of the lung for carbon monoxide (ppDLCO SB) (corrected for hemoglobin) from baseline
Timepoint [23] 0 0
At Week 52
Secondary outcome [24] 0 0
Change from baseline in quantitative lung fibrosis (QLF) score via high-resolution computed tomography (HRCT)
Timepoint [24] 0 0
At Week 52
Secondary outcome [25] 0 0
Number of participants with Adverse Events (AEs)
Timepoint [25] 0 0
Up to 28 days after last dose
Secondary outcome [26] 0 0
Number of participants with Serious AEs (SAEs)
Timepoint [26] 0 0
Up to 28 days after last dose
Secondary outcome [27] 0 0
Number of participants with AEs leading to early discontinuation of investigational medicinal product (IMP)
Timepoint [27] 0 0
Up to 28 days after last dose
Secondary outcome [28] 0 0
Number of participants with AEs related to IMP
Timepoint [28] 0 0
Up to 28 days after last dose
Secondary outcome [29] 0 0
Number of treatment-emergent deaths
Timepoint [29] 0 0
Up to 28 days after last dose
Secondary outcome [30] 0 0
Number of participants with clinical laboratory abnormalities
Timepoint [30] 0 0
Up to 28 days after last dose
Secondary outcome [31] 0 0
Number of participants with electrocardiogram (ECG) abnormalities
Timepoint [31] 0 0
Up to 28 days after last dose
Secondary outcome [32] 0 0
Number of participants with vital sign abnormalities
Timepoint [32] 0 0
Up to 28 days after last dose

Eligibility
Key inclusion criteria
Inclusion Criteria

* Diagnosis of interstitial lung disease (ILD) with features consistent with progressive ILD within 24 months prior to screening, and = 10% extent of fibrosis on screening high-resolution computed tomography (HRCT).
* If on pirfenidone or nintedanib, participants must have been on a stable dose for at least 90 days prior to screening.
* If not currently on pirfenidone or nintedanib, participants must not have received either of these medications within 28 days prior to screening.
* Mycophenolate mofetil (MMF), mycophenolic acid (MA), azathioprine (AZA), and Tacrolimus are permitted provided that the participant is on a stable dose for at least 90 days prior to screening. If not currently on MMF, MA, AZA, or tacrolimus, participants must not have taken these medications within 28 days prior to screening.
* Traditional disease-modifying antirheumatic drug (DMARDs) (eg. Methotrexate, leflunomide, sulfasalazine, or hydroxychloroquine) are permitted provided that the participant is on a stable dose for at least 90 days prior to screening. If not currently on traditional DMARD, participants must not have taken these medications within 28 days prior to screening.
* Biologic DMARDs (eg. TNF blockers and IL-1 inhibitors) and Janus kinase inhibitors (JAK inhibitors eg. tofacitinib, upadacitinib) are permitted provided that the participant is on a stable dose for at least 90 days prior to screening. If not currently on Biologic DMARD or JAK inhibitor, participants must not have taken these medications within 28 days prior to screening.
* Women who are of childbearing potential must have a highly effective form of contraception and must provide a negative urine/serum pregnancy test.
* Men who are sexually active with women of childbearing potential agree to use male barrier contraception.
Minimum age
21 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Exclusion Criteria

* Idiopathic pulmonary fibrosis with usual interstitial pneumonia (UIP) verification at screening.
* History of stroke or transient ischemic attack within 3 months prior to screening.
* Participants who exhibit symptoms of heart failure at rest.
* Participants who have a current malignancy or a previous malignancy in the past 5 years prior to screening, except for those who have a documented history of cured nonmetastatic squamous cell skin carcinoma, basal cell skin carcinoma, or cervical carcinoma in situ.
* Use of systemic corticosteroids equivalent to prednisone > 15 mg/day is not allowed within 4 weeks prior to screening and during the study.
* Other protocol-defined Inclusion/Exclusion criteria apply.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s
The people administering the treatment/s
The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Phase 3
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
25/10/2023
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
27/12/2027
Actual
Sample size
Target
1092
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW,QLD,SA,VIC,WA
Recruitment hospital [1] 0 0
Local Institution - 0065 - Camperdown
Recruitment hospital [2] 0 0
Local Institution - 0467 - Darlinghurst
Recruitment hospital [3] 0 0
Local Institution - 0089 - Westmead
Recruitment hospital [4] 0 0
Local Institution - 0090 - Brisbane
Recruitment hospital [5] 0 0
Local Institution - 0499 - Chermside
Recruitment hospital [6] 0 0
Local Institution - 0091 - Greenslopes
Recruitment hospital [7] 0 0
Local Institution - 0342 - South Brisbane
Recruitment hospital [8] 0 0
Local Institution - 0275 - Adelaide
Recruitment hospital [9] 0 0
Local Institution - 0359 - Box Hill
Recruitment hospital [10] 0 0
Local Institution - 0299 - Heidelberg,VIC
Recruitment hospital [11] 0 0
Local Institution - 0059 - Melbourne
Recruitment hospital [12] 0 0
Local Institution - 0303 - Murdoch
Recruitment hospital [13] 0 0
Local Institution - 0459 - Nedlands
Recruitment postcode(s) [1] 0 0
2050 - Camperdown
Recruitment postcode(s) [2] 0 0
2010 - Darlinghurst
Recruitment postcode(s) [3] 0 0
2145 - Westmead
Recruitment postcode(s) [4] 0 0
4032 - Brisbane
Recruitment postcode(s) [5] 0 0
4032 - Chermside
Recruitment postcode(s) [6] 0 0
4120 - Greenslopes
Recruitment postcode(s) [7] 0 0
4101 - South Brisbane
Recruitment postcode(s) [8] 0 0
5000 - Adelaide
Recruitment postcode(s) [9] 0 0
3128 - Box Hill
Recruitment postcode(s) [10] 0 0
3084 - Heidelberg,VIC
Recruitment postcode(s) [11] 0 0
3004 - Melbourne
Recruitment postcode(s) [12] 0 0
6150 - Murdoch
Recruitment postcode(s) [13] 0 0
6009 - Nedlands
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
Alabama
Country [2] 0 0
United States of America
State/province [2] 0 0
Arizona
Country [3] 0 0
United States of America
State/province [3] 0 0
California
Country [4] 0 0
United States of America
State/province [4] 0 0
Colorado
Country [5] 0 0
United States of America
State/province [5] 0 0
Connecticut
Country [6] 0 0
United States of America
State/province [6] 0 0
Delaware
Country [7] 0 0
United States of America
State/province [7] 0 0
District of Columbia
Country [8] 0 0
United States of America
State/province [8] 0 0
Florida
Country [9] 0 0
United States of America
State/province [9] 0 0
Georgia
Country [10] 0 0
United States of America
State/province [10] 0 0
Illinois
Country [11] 0 0
United States of America
State/province [11] 0 0
Indiana
Country [12] 0 0
United States of America
State/province [12] 0 0
Iowa
Country [13] 0 0
United States of America
State/province [13] 0 0
Kansas
Country [14] 0 0
United States of America
State/province [14] 0 0
Kentucky
Country [15] 0 0
United States of America
State/province [15] 0 0
Maryland
Country [16] 0 0
United States of America
State/province [16] 0 0
Massachusetts
Country [17] 0 0
United States of America
State/province [17] 0 0
Michigan
Country [18] 0 0
United States of America
State/province [18] 0 0
Minnesota
Country [19] 0 0
United States of America
State/province [19] 0 0
Missouri
Country [20] 0 0
United States of America
State/province [20] 0 0
New Jersey
Country [21] 0 0
United States of America
State/province [21] 0 0
New York
Country [22] 0 0
United States of America
State/province [22] 0 0
North Carolina
Country [23] 0 0
United States of America
State/province [23] 0 0
Ohio
Country [24] 0 0
United States of America
State/province [24] 0 0
Oklahoma
Country [25] 0 0
United States of America
State/province [25] 0 0
Oregon
Country [26] 0 0
United States of America
State/province [26] 0 0
Pennsylvania
Country [27] 0 0
United States of America
State/province [27] 0 0
South Carolina
Country [28] 0 0
United States of America
State/province [28] 0 0
Tennessee
Country [29] 0 0
United States of America
State/province [29] 0 0
Texas
Country [30] 0 0
United States of America
State/province [30] 0 0
Utah
Country [31] 0 0
United States of America
State/province [31] 0 0
Vermont
Country [32] 0 0
United States of America
State/province [32] 0 0
Virginia
Country [33] 0 0
United States of America
State/province [33] 0 0
Washington
Country [34] 0 0
United States of America
State/province [34] 0 0
Wisconsin
Country [35] 0 0
Argentina
State/province [35] 0 0
Buenos Aires
Country [36] 0 0
Argentina
State/province [36] 0 0
B
Country [37] 0 0
Argentina
State/province [37] 0 0
C
Country [38] 0 0
Argentina
State/province [38] 0 0
Distrito Federal
Country [39] 0 0
Argentina
State/province [39] 0 0
M
Country [40] 0 0
Argentina
State/province [40] 0 0
S
Country [41] 0 0
Argentina
State/province [41] 0 0
T
Country [42] 0 0
Argentina
State/province [42] 0 0
Cordoba
Country [43] 0 0
Argentina
State/province [43] 0 0
Santa Fe
Country [44] 0 0
Austria
State/province [44] 0 0
Oberoesterreich
Country [45] 0 0
Austria
State/province [45] 0 0
Salzburger Land
Country [46] 0 0
Austria
State/province [46] 0 0
Styria
Country [47] 0 0
Austria
State/province [47] 0 0
Vienna
Country [48] 0 0
Austria
State/province [48] 0 0
Wien
Country [49] 0 0
Belgium
State/province [49] 0 0
Namur
Country [50] 0 0
Belgium
State/province [50] 0 0
VAN
Country [51] 0 0
Belgium
State/province [51] 0 0
VBR
Country [52] 0 0
Belgium
State/province [52] 0 0
Brussels
Country [53] 0 0
Belgium
State/province [53] 0 0
Kortrijk
Country [54] 0 0
Belgium
State/province [54] 0 0
Liege
Country [55] 0 0
Brazil
State/province [55] 0 0
BA
Country [56] 0 0
Brazil
State/province [56] 0 0
MG
Country [57] 0 0
Brazil
State/province [57] 0 0
Minas Gerais
Country [58] 0 0
Brazil
State/province [58] 0 0
Rio Grande Do Sul
Country [59] 0 0
Brazil
State/province [59] 0 0
RJ
Country [60] 0 0
Brazil
State/province [60] 0 0
RS
Country [61] 0 0
Brazil
State/province [61] 0 0
Salvador
Country [62] 0 0
Brazil
State/province [62] 0 0
SAO Paulo
Country [63] 0 0
Brazil
State/province [63] 0 0
SC
Country [64] 0 0
Brazil
State/province [64] 0 0
SP
Country [65] 0 0
Brazil
State/province [65] 0 0
Porto Alegre
Country [66] 0 0
Brazil
State/province [66] 0 0
Sao Paulo
Country [67] 0 0
Brazil
State/province [67] 0 0
São Paulo
Country [68] 0 0
Canada
State/province [68] 0 0
Alberta
Country [69] 0 0
Canada
State/province [69] 0 0
British Columbia
Country [70] 0 0
Canada
State/province [70] 0 0
Ontario
Country [71] 0 0
Canada
State/province [71] 0 0
Quebec
Country [72] 0 0
Chile
State/province [72] 0 0
BI
Country [73] 0 0
Chile
State/province [73] 0 0
Maule
Country [74] 0 0
Chile
State/province [74] 0 0
RM
Country [75] 0 0
Chile
State/province [75] 0 0
VS
Country [76] 0 0
Chile
State/province [76] 0 0
Santiago
Country [77] 0 0
Chile
State/province [77] 0 0
Vina del Mar
Country [78] 0 0
China
State/province [78] 0 0
AH
Country [79] 0 0
China
State/province [79] 0 0
Beijing
Country [80] 0 0
China
State/province [80] 0 0
Gansu
Country [81] 0 0
China
State/province [81] 0 0
Guangdong
Country [82] 0 0
China
State/province [82] 0 0
Hainan
Country [83] 0 0
China
State/province [83] 0 0
Hebei
Country [84] 0 0
China
State/province [84] 0 0
Hebi
Country [85] 0 0
China
State/province [85] 0 0
Hubei
Country [86] 0 0
China
State/province [86] 0 0
HUB
Country [87] 0 0
China
State/province [87] 0 0
Hunan
Country [88] 0 0
China
State/province [88] 0 0
Jiangsu
Country [89] 0 0
China
State/province [89] 0 0
Jiangxi
Country [90] 0 0
China
State/province [90] 0 0
Liaoning
Country [91] 0 0
China
State/province [91] 0 0
Shan3xi
Country [92] 0 0
China
State/province [92] 0 0
Shanghai Sheng
Country [93] 0 0
China
State/province [93] 0 0
Shanghai
Country [94] 0 0
China
State/province [94] 0 0
Sichuan
Country [95] 0 0
China
State/province [95] 0 0
Tianjin
Country [96] 0 0
China
State/province [96] 0 0
Yinchuan
Country [97] 0 0
China
State/province [97] 0 0
Zhejiang
Country [98] 0 0
China
State/province [98] 0 0
Changsha
Country [99] 0 0
China
State/province [99] 0 0
Chengdu Shi
Country [100] 0 0
China
State/province [100] 0 0
Hefei Shi
Country [101] 0 0
China
State/province [101] 0 0
Hohhot
Country [102] 0 0
China
State/province [102] 0 0
Jinan Shi
Country [103] 0 0
China
State/province [103] 0 0
Shijiazhuang
Country [104] 0 0
Colombia
State/province [104] 0 0
ANT
Country [105] 0 0
Colombia
State/province [105] 0 0
CL
Country [106] 0 0
Colombia
State/province [106] 0 0
Cundinamarca
Country [107] 0 0
Colombia
State/province [107] 0 0
DC
Country [108] 0 0
Colombia
State/province [108] 0 0
Santander
Country [109] 0 0
Colombia
State/province [109] 0 0
VAC
Country [110] 0 0
Colombia
State/province [110] 0 0
Bogota
Country [111] 0 0
Czechia
State/province [111] 0 0
OL
Country [112] 0 0
Czechia
State/province [112] 0 0
Prague
Country [113] 0 0
Denmark
State/province [113] 0 0
Region Midtjylland
Country [114] 0 0
Denmark
State/province [114] 0 0
Region Syddanmark
Country [115] 0 0
Denmark
State/province [115] 0 0
Copenhagen
Country [116] 0 0
Denmark
State/province [116] 0 0
Hellerup
Country [117] 0 0
Finland
State/province [117] 0 0
Etelae-Suomen Laeaeni
Country [118] 0 0
Finland
State/province [118] 0 0
Laensi-Suomen Laeaeni
Country [119] 0 0
France
State/province [119] 0 0
Auvergne-Rhône-Alpes
Country [120] 0 0
France
State/province [120] 0 0
Pays De La Loire
Country [121] 0 0
France
State/province [121] 0 0
Provence-Alpes-Côte d'Azur
Country [122] 0 0
France
State/province [122] 0 0
Bobigny
Country [123] 0 0
France
State/province [123] 0 0
Brest
Country [124] 0 0
France
State/province [124] 0 0
Dijon Cedex
Country [125] 0 0
France
State/province [125] 0 0
Lille CEDEX
Country [126] 0 0
France
State/province [126] 0 0
Nice
Country [127] 0 0
France
State/province [127] 0 0
Paris
Country [128] 0 0
France
State/province [128] 0 0
Pessac
Country [129] 0 0
France
State/province [129] 0 0
Rennes
Country [130] 0 0
France
State/province [130] 0 0
Toulouse
Country [131] 0 0
France
State/province [131] 0 0
Tours
Country [132] 0 0
France
State/province [132] 0 0
Île-de-France
Country [133] 0 0
Germany
State/province [133] 0 0
Bavaria
Country [134] 0 0
Germany
State/province [134] 0 0
Berlin
Country [135] 0 0
Germany
State/province [135] 0 0
BE
Country [136] 0 0
Germany
State/province [136] 0 0
BW
Country [137] 0 0
Germany
State/province [137] 0 0
BY
Country [138] 0 0
Germany
State/province [138] 0 0
HE
Country [139] 0 0
Germany
State/province [139] 0 0
HH
Country [140] 0 0
Germany
State/province [140] 0 0
MV
Country [141] 0 0
Germany
State/province [141] 0 0
Nordrhein Westfalen
Country [142] 0 0
Germany
State/province [142] 0 0
Northwest
Country [143] 0 0
Germany
State/province [143] 0 0
SH
Country [144] 0 0
Germany
State/province [144] 0 0
Coswig
Country [145] 0 0
Germany
State/province [145] 0 0
Heidelberg
Country [146] 0 0
Germany
State/province [146] 0 0
Leipzig
Country [147] 0 0
Germany
State/province [147] 0 0
Mainz
Country [148] 0 0
Greece
State/province [148] 0 0
Attica
Country [149] 0 0
Greece
State/province [149] 0 0
Epirus
Country [150] 0 0
Greece
State/province [150] 0 0
Iraklio Kritis
Country [151] 0 0
Greece
State/province [151] 0 0
Thessaloniki
Country [152] 0 0
Greece
State/province [152] 0 0
Athens
Country [153] 0 0
Greece
State/province [153] 0 0
Corfu
Country [154] 0 0
Greece
State/province [154] 0 0
Larisa
Country [155] 0 0
Greece
State/province [155] 0 0
Rio
Country [156] 0 0
Hungary
State/province [156] 0 0
Budapest
Country [157] 0 0
Hungary
State/province [157] 0 0
Györ
Country [158] 0 0
India
State/province [158] 0 0
Delhi
Country [159] 0 0
India
State/province [159] 0 0
GJ
Country [160] 0 0
India
State/province [160] 0 0
Gujarat
Country [161] 0 0
India
State/province [161] 0 0
HR
Country [162] 0 0
India
State/province [162] 0 0
Karnataka
Country [163] 0 0
India
State/province [163] 0 0
KA
Country [164] 0 0
India
State/province [164] 0 0
Maharashtra
Country [165] 0 0
India
State/province [165] 0 0
MH
Country [166] 0 0
India
State/province [166] 0 0
RJ
Country [167] 0 0
India
State/province [167] 0 0
TN
Country [168] 0 0
India
State/province [168] 0 0
UP
Country [169] 0 0
India
State/province [169] 0 0
Uttar Pradesh
Country [170] 0 0
India
State/province [170] 0 0
UT
Country [171] 0 0
India
State/province [171] 0 0
WB
Country [172] 0 0
India
State/province [172] 0 0
Ahmedabad
Country [173] 0 0
India
State/province [173] 0 0
Bhopal
Country [174] 0 0
India
State/province [174] 0 0
Lucknow
Country [175] 0 0
Ireland
State/province [175] 0 0
LH
Country [176] 0 0
Ireland
State/province [176] 0 0
Dublin
Country [177] 0 0
Israel
State/province [177] 0 0
Central District
Country [178] 0 0
Israel
State/province [178] 0 0
D
Country [179] 0 0
Israel
State/province [179] 0 0
HA
Country [180] 0 0
Israel
State/province [180] 0 0
M
Country [181] 0 0
Israel
State/province [181] 0 0
TA
Country [182] 0 0
Israel
State/province [182] 0 0
Haifa
Country [183] 0 0
Israel
State/province [183] 0 0
Jerusalem
Country [184] 0 0
Israel
State/province [184] 0 0
Petah-Tikva
Country [185] 0 0
Italy
State/province [185] 0 0
AN
Country [186] 0 0
Italy
State/province [186] 0 0
Emilia-Romagna
Country [187] 0 0
Italy
State/province [187] 0 0
FI
Country [188] 0 0
Italy
State/province [188] 0 0
MI
Country [189] 0 0
Italy
State/province [189] 0 0
PI
Country [190] 0 0
Italy
State/province [190] 0 0
RM
Country [191] 0 0
Italy
State/province [191] 0 0
TS
Country [192] 0 0
Italy
State/province [192] 0 0
Bergamo
Country [193] 0 0
Italy
State/province [193] 0 0
Foggia
Country [194] 0 0
Italy
State/province [194] 0 0
Forli
Country [195] 0 0
Italy
State/province [195] 0 0
Milano
Country [196] 0 0
Italy
State/province [196] 0 0
Milan
Country [197] 0 0
Italy
State/province [197] 0 0
Monza
Country [198] 0 0
Italy
State/province [198] 0 0
Napoli
Country [199] 0 0
Italy
State/province [199] 0 0
Palermo
Country [200] 0 0
Italy
State/province [200] 0 0
Pavia
Country [201] 0 0
Italy
State/province [201] 0 0
Sassari
Country [202] 0 0
Italy
State/province [202] 0 0
Siena
Country [203] 0 0
Japan
State/province [203] 0 0
Aichi-Ken
Country [204] 0 0
Japan
State/province [204] 0 0
Fukui
Country [205] 0 0
Japan
State/province [205] 0 0
Fukuoka
Country [206] 0 0
Japan
State/province [206] 0 0
Fukushima
Country [207] 0 0
Japan
State/province [207] 0 0
Hirohima-ken
Country [208] 0 0
Japan
State/province [208] 0 0
Hokkaido
Country [209] 0 0
Japan
State/province [209] 0 0
Kanagawa
Country [210] 0 0
Japan
State/province [210] 0 0
Mie
Country [211] 0 0
Japan
State/province [211] 0 0
Osaka
Country [212] 0 0
Japan
State/province [212] 0 0
OSK
Country [213] 0 0
Japan
State/province [213] 0 0
Shimane
Country [214] 0 0
Japan
State/province [214] 0 0
TKY
Country [215] 0 0
Japan
State/province [215] 0 0
Tochigi
Country [216] 0 0
Japan
State/province [216] 0 0
Tokushima-Ken
Country [217] 0 0
Japan
State/province [217] 0 0
Tokyo-to
Country [218] 0 0
Japan
State/province [218] 0 0
Tokyo
Country [219] 0 0
Japan
State/province [219] 0 0
Bunkyo-Ku
Country [220] 0 0
Japan
State/province [220] 0 0
Chiba-shi
Country [221] 0 0
Japan
State/province [221] 0 0
Chikushino
Country [222] 0 0
Japan
State/province [222] 0 0
Hamamatsu-shi
Country [223] 0 0
Japan
State/province [223] 0 0
Himeji-Shi
Country [224] 0 0
Japan
State/province [224] 0 0
Iizuka-shi
Country [225] 0 0
Japan
State/province [225] 0 0
Kamogawa-Shi
Country [226] 0 0
Japan
State/province [226] 0 0
Kobe-shi
Country [227] 0 0
Japan
State/province [227] 0 0
Kumamoto
Country [228] 0 0
Japan
State/province [228] 0 0
Kurume-Shi
Country [229] 0 0
Japan
State/province [229] 0 0
Nagasaki-Shi
Country [230] 0 0
Japan
State/province [230] 0 0
Naka-Gun
Country [231] 0 0
Japan
State/province [231] 0 0
Seto
Country [232] 0 0
Japan
State/province [232] 0 0
Shinjuku-Ku
Country [233] 0 0
Japan
State/province [233] 0 0
Shinjyu-Ku
Country [234] 0 0
Japan
State/province [234] 0 0
Takatsuki-Shi
Country [235] 0 0
Japan
State/province [235] 0 0
Tenri-Shi
Country [236] 0 0
Japan
State/province [236] 0 0
Toyoake-Shi
Country [237] 0 0
Japan
State/province [237] 0 0
Yokohama-Shi
Country [238] 0 0
Korea, Republic of
State/province [238] 0 0
Gyeonggi-Do
Country [239] 0 0
Korea, Republic of
State/province [239] 0 0
Gyeonggi
Country [240] 0 0
Korea, Republic of
State/province [240] 0 0
Seoul
Country [241] 0 0
Korea, Republic of
State/province [241] 0 0
Ulsan
Country [242] 0 0
Korea, Republic of
State/province [242] 0 0
Bucheon-Si
Country [243] 0 0
Korea, Republic of
State/province [243] 0 0
Bucheonsi Weonmigu
Country [244] 0 0
Korea, Republic of
State/province [244] 0 0
Busan
Country [245] 0 0
Korea, Republic of
State/province [245] 0 0
Gyeonggi-do
Country [246] 0 0
Korea, Republic of
State/province [246] 0 0
Haeundae-Gu
Country [247] 0 0
Korea, Republic of
State/province [247] 0 0
Iksansi
Country [248] 0 0
Korea, Republic of
State/province [248] 0 0
Incheon
Country [249] 0 0
Korea, Republic of
State/province [249] 0 0
Suwon
Country [250] 0 0
Malaysia
State/province [250] 0 0
Selangor Darul Ehsan
Country [251] 0 0
Malaysia
State/province [251] 0 0
Wilayah Persekutuan Kuala Lumpur
Country [252] 0 0
Malaysia
State/province [252] 0 0
Kuching
Country [253] 0 0
Mexico
State/province [253] 0 0
AGU
Country [254] 0 0
Mexico
State/province [254] 0 0
Cdmx
Country [255] 0 0
Mexico
State/province [255] 0 0
CHH
Country [256] 0 0
Mexico
State/province [256] 0 0
JAL
Country [257] 0 0
Mexico
State/province [257] 0 0
MIC
Country [258] 0 0
Mexico
State/province [258] 0 0
Nuevo León
Country [259] 0 0
Mexico
State/province [259] 0 0
OAX
Country [260] 0 0
Mexico
State/province [260] 0 0
VER
Country [261] 0 0
Mexico
State/province [261] 0 0
YUC
Country [262] 0 0
Mexico
State/province [262] 0 0
Guadalajara
Country [263] 0 0
Mexico
State/province [263] 0 0
Mexico City
Country [264] 0 0
Netherlands
State/province [264] 0 0
Limburg
Country [265] 0 0
Netherlands
State/province [265] 0 0
South Holland
Country [266] 0 0
Netherlands
State/province [266] 0 0
Utrecht
Country [267] 0 0
Netherlands
State/province [267] 0 0
Amsterdam
Country [268] 0 0
Peru
State/province [268] 0 0
Lima
Country [269] 0 0
Peru
State/province [269] 0 0
LIM
Country [270] 0 0
Peru
State/province [270] 0 0
PIU
Country [271] 0 0
Poland
State/province [271] 0 0
KP
Country [272] 0 0
Poland
State/province [272] 0 0
Malopolskie
Country [273] 0 0
Poland
State/province [273] 0 0
PD
Country [274] 0 0
Poland
State/province [274] 0 0
Pomorskie
Country [275] 0 0
Poland
State/province [275] 0 0
WN
Country [276] 0 0
Poland
State/province [276] 0 0
Bedzin
Country [277] 0 0
Poland
State/province [277] 0 0
Katowice
Country [278] 0 0
Poland
State/province [278] 0 0
Lodz
Country [279] 0 0
Portugal
State/province [279] 0 0
Braga
Country [280] 0 0
Portugal
State/province [280] 0 0
Lisboa
Country [281] 0 0
Portugal
State/province [281] 0 0
Loures
Country [282] 0 0
Portugal
State/province [282] 0 0
Porto
Country [283] 0 0
Portugal
State/province [283] 0 0
Vila Nova de Gaia
Country [284] 0 0
Puerto Rico
State/province [284] 0 0
Guaynabo
Country [285] 0 0
Spain
State/province [285] 0 0
Asturias
Country [286] 0 0
Spain
State/province [286] 0 0
B
Country [287] 0 0
Spain
State/province [287] 0 0
CB
Country [288] 0 0
Spain
State/province [288] 0 0
Comunidad Valencia
Country [289] 0 0
Spain
State/province [289] 0 0
Galicia
Country [290] 0 0
Spain
State/province [290] 0 0
M
Country [291] 0 0
Spain
State/province [291] 0 0
Barcelona
Country [292] 0 0
Spain
State/province [292] 0 0
Madrid
Country [293] 0 0
Spain
State/province [293] 0 0
Pamplona
Country [294] 0 0
Spain
State/province [294] 0 0
Santa Cruz de Tenerife
Country [295] 0 0
Switzerland
State/province [295] 0 0
BE
Country [296] 0 0
Switzerland
State/province [296] 0 0
BS
Country [297] 0 0
Switzerland
State/province [297] 0 0
Geneve
Country [298] 0 0
Switzerland
State/province [298] 0 0
St Gallen
Country [299] 0 0
Taiwan
State/province [299] 0 0
Kao-Hsiung
Country [300] 0 0
Taiwan
State/province [300] 0 0
Sanmin District
Country [301] 0 0
Taiwan
State/province [301] 0 0
TXG
Country [302] 0 0
Taiwan
State/province [302] 0 0
YUN
Country [303] 0 0
Taiwan
State/province [303] 0 0
Taichung
Country [304] 0 0
Taiwan
State/province [304] 0 0
Taipei City
Country [305] 0 0
Taiwan
State/province [305] 0 0
Taipei
Country [306] 0 0
Thailand
State/province [306] 0 0
Bangkok
Country [307] 0 0
Thailand
State/province [307] 0 0
Chiang Mai
Country [308] 0 0
Thailand
State/province [308] 0 0
Khon Kaen
Country [309] 0 0
Thailand
State/province [309] 0 0
Songkla
Country [310] 0 0
Turkey
State/province [310] 0 0
Adana
Country [311] 0 0
Turkey
State/province [311] 0 0
Istanbul
Country [312] 0 0
Turkey
State/province [312] 0 0
Ankara
Country [313] 0 0
Turkey
State/province [313] 0 0
Bursa
Country [314] 0 0
Turkey
State/province [314] 0 0
Guemueshane
Country [315] 0 0
Turkey
State/province [315] 0 0
Izmir
Country [316] 0 0
Turkey
State/province [316] 0 0
Keçiören/Ankara
Country [317] 0 0
Turkey
State/province [317] 0 0
Maltepe
Country [318] 0 0
Turkey
State/province [318] 0 0
Pasaport
Country [319] 0 0
Turkey
State/province [319] 0 0
Topkapi
Country [320] 0 0
United Kingdom
State/province [320] 0 0
BST
Country [321] 0 0
United Kingdom
State/province [321] 0 0
Cambridgeshire
Country [322] 0 0
United Kingdom
State/province [322] 0 0
DND
Country [323] 0 0
United Kingdom
State/province [323] 0 0
EDH
Country [324] 0 0
United Kingdom
State/province [324] 0 0
Greater London
Country [325] 0 0
United Kingdom
State/province [325] 0 0
Hampshire
Country [326] 0 0
United Kingdom
State/province [326] 0 0
LND
Country [327] 0 0
United Kingdom
State/province [327] 0 0
Nottinghamshire
Country [328] 0 0
United Kingdom
State/province [328] 0 0
Oxfordshire
Country [329] 0 0
United Kingdom
State/province [329] 0 0
South West
Country [330] 0 0
United Kingdom
State/province [330] 0 0
STY
Country [331] 0 0
United Kingdom
State/province [331] 0 0
West Midlands
Country [332] 0 0
United Kingdom
State/province [332] 0 0
West Yorkshire
Country [333] 0 0
United Kingdom
State/province [333] 0 0
Yorkshire And The Humber
Country [334] 0 0
United Kingdom
State/province [334] 0 0
Birmingham

Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Name
Bristol-Myers Squibb
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis.
Trial website
https://clinicaltrials.gov/study/NCT06025578
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Bristol-Myers Squibb
Address 0 0
Bristol-Myers Squibb
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
Address 0 0
Country 0 0
Phone 0 0
855-907-3286
Fax 0 0
Email 0 0
Clinical.Trials@bms.com
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/study/NCT06025578